Musculoskeletal/Rheumatology

Long-term benefit of teriparatide for osteoporosis shown over 10-year follow-up

At 10 years follow-up, patients with osteoporosis treated with teriparatide had reduced fracture occurrence that was similar to the general population, however, Health Related Quality of Life remained low according to a study. This analysis included 40 women with osteoporosis and vertebral compression who received teriparatide 20 μg given subcutaneously...